Amedisys Inc (AMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 138,863 | 54,133 | 45,769 | 83,357 | 96,490 |
| Receivables | 313,373 | 296,785 | 274,961 | 255,145 | 237,596 |
| Other current assets | 30,060 | 26,415 | 25,598 | 13,265 | 8,225 |
| TOTAL | $496,935 | $388,961 | $356,684 | $361,984 | $350,554 |
| Non-Current Assets | |||||
| PPE Net | 41,845 | 16,026 | 18,435 | 23,719 | 28,113 |
| Intangibles | 1,347,354 | 1,388,566 | 1,307,280 | 1,006,868 | 723,248 |
| Other Non-Current Assets | 174,036 | 182,692 | 174,569 | 174,627 | 160,830 |
| TOTAL | $1,563,235 | $1,587,284 | $1,500,284 | $1,205,214 | $912,191 |
| Total Assets | $2,060,170 | $1,976,245 | $1,856,968 | $1,567,198 | $1,262,745 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 36,314 | 15,496 | 12,995 | 10,496 | 9,927 |
| Accounts payable and accrued liabilities | 28,237 | 43,735 | 38,217 | 42,674 | 31,259 |
| Accrued Expenses | 276,884 | 262,777 | 291,837 | 313,121 | 257,988 |
| Other current liabilities | 106,000 | N/A | N/A | 60,000 | N/A |
| TOTAL | $473,721 | $355,529 | $374,282 | $456,337 | $326,943 |
| Non-Current Liabilities | |||||
| Long Term Debt | 361,862 | 419,420 | 432,075 | 204,511 | 232,256 |
| Other Non-Current Liabilities | 65,358 | 75,222 | 73,194 | 94,033 | 60,959 |
| TOTAL | $466,666 | $514,143 | $506,363 | $300,120 | $294,289 |
| Total Liabilities | $940,387 | $869,672 | $880,645 | $756,457 | $621,232 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,668 | 32,551 | 32,526 | 32,849 | 32,314 |
| Common Shares | 38 | 38 | 38 | 38 | 37 |
| Retained earnings | 747,925 | 757,672 | 639,063 | 429,991 | 246,383 |
| Other shareholders' equity | 53,643 | 54,800 | 45,104 | 1,425 | 837 |
| TOTAL | $1,119,783 | $1,106,573 | $976,323 | $810,741 | $641,513 |
| Total Liabilities And Equity | $2,060,170 | $1,976,245 | $1,856,968 | $1,567,198 | $1,262,745 |